| 1 |
33275878 | Advantages of brain penetrating inhibitors of kynurenine-3-monooxygenase for treatment of neurodegenerative diseases. | 2021 Jan 15 |
1 |
| 2 |
32148781 | Kynurenine-3-monooxygenase: A new direction for the treatment in different diseases. | 2020 Feb |
2 |
| 3 |
27245499 | The kynurenine pathway in schizophrenia and bipolar disorder. | 2017 Jan |
2 |
| 4 |
28187857 | Adaptive and Behavioral Changes in Kynurenine 3-Monooxygenase Knockout Mice: Relevance to Psychotic Disorders. | 2017 Nov 15 |
1 |
| 5 |
25540092 | Etiological classification of depression based on the enzymes of tryptophan metabolism. | 2014 Dec 24 |
2 |
| 6 |
21693093 | Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls. | 2012 Jan |
1 |
| 7 |
19226371 | On the relationship between the two branches of the kynurenine pathway in the rat brain in vivo. | 2009 Apr |
4 |
| 8 |
15206781 | Modulation of the kynurine pathway of tryptophan metabolism in search for neuroprotective agents. Focus on kynurenine-3-hydroxylase. | 2003 |
1 |
| 9 |
12354294 | Kynurenine 3-mono-oxygenase inhibitors attenuate post-ischemic neuronal death in organotypic hippocampal slice cultures. | 2002 Sep |
2 |
| 10 |
8906269 | Kynurenic acid-enhancing and anti-ischemic effects of the potent kynurenine 3-hydroxylase inhibitor FCE 28833 in rodents. | 1996 |
1 |